Literature DB >> 15831499

Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.

Shang Li1, Julia Crothers, Christopher M Haqq, Elizabeth H Blackburn.   

Abstract

Inhibition of the up-regulated telomerase activity in cancer cells has previously been shown to slow cell growth but only after prior telomere shortening. Previously, we have reported that, unexpectedly, a hairpin short interfering RNA specifically targeting human telomerase RNA rapidly inhibits the growth of human cancer cells independently of p53 or telomere length and without bulk telomere shortening (Li, S., Rosenberg, J. E., Donjacour, A. A., Botchkina, I. L., Hom, Y. K., Cunha, G. R., and Blackburn, E. H. (2004) Cancer Res. 64, 4833-4840). Here we have demonstrated that such telomerase RNA knockdown in cancer cells does not cause telomere uncapping but rather induces changes in the global gene expression profile indicative of a novel response pathway, which includes suppression of specific genes implicated in angiogenesis and metastasis, and is distinct from the expression profile changes induced by telomere-uncapping mutant template telomerase RNAs. These cellular responses to depleting telomerase in human cancer cells together suggest that cancer cells are "telomerase-addicted" and uncover functions of telomerase in tumor growth and progression in addition to telomere maintenance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831499     DOI: 10.1074/jbc.M502782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Genes and pathways downstream of telomerase in melanoma metastasis.

Authors:  Sepideh Bagheri; Mehdi Nosrati; Shang Li; Sylvia Fong; Sima Torabian; Javier Rangel; Dan H Moore; Scot Federman; Rebecca R Laposa; Frederick L Baehner; Richard W Sagebiel; James E Cleaver; Christopher Haqq; Robert J Debs; Elizabeth H Blackburn; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

2.  Integrated nanosensors to determine levels and functional activity of human telomerase.

Authors:  J Manuel Perez; Jan Grimm; Lee Josephson; Ralph Weissleder
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 3.  Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.

Authors:  Dora Melicher; Edit I Buzas; Andras Falus
Journal:  Cell Mol Life Sci       Date:  2015-07-20       Impact factor: 9.261

Review 4.  Human telomerase inhibitors from microbial source.

Authors:  Kalarikkal Gopikrishnan Kiran; Muthusamy Palaniswamy; Jayaraman Angayarkanni
Journal:  World J Microbiol Biotechnol       Date:  2015-07-01       Impact factor: 3.312

5.  RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells.

Authors:  Ch Lavanya; M K Sibin; M M Srinivas Bharath; M Jeru Manoj; Manjunatha M Venkataswamy; Dhananjaya I Bhat; K V L Narasinga Rao; G K Chetan
Journal:  Cytotechnology       Date:  2016-10-18       Impact factor: 2.058

Review 6.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

7.  Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress.

Authors:  Olga A Kovalenko; Jessica Kaplunov; Utz Herbig; Sonia Detoledo; Edouard I Azzam; Janine H Santos
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

8.  Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.

Authors:  Sarah K Brennan; Qiuju Wang; Robert Tressler; Calvin Harley; Ning Go; Ekaterina Bassett; Carol Ann Huff; Richard J Jones; William Matsui
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase.

Authors:  Sofia L Vidal-Cardenas; Carol W Greider
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.